Unfavorable developments in the incidence of hypercholesterolemia (high cholesterol) and clinical complications related to atherosclerosis throughout the industrialized world makes the search for natural substances with hypocholesterolemic eff ects highly important. Th e role of dietary fi ber in lipid metabolism and athergensis has been extensively studied; however, the focus has been on the fi bers of vegetable, fruit, and cereal origin. Mushrooms contain high fi ber content, sterols, proteins, and microelements. Th ese, along with their low caloric content, makes mushrooms ideal for a nutrition program aimed at the prevention of cardiovascular disease.
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Th is work has been carried out to investigate the hypocholesterolemic eff ect of oyster mushroom Pleurotus ostreatus ( Jacq.: Fr.) P. Kumm. and its ethanolic extract on hamsters fed a hyperlipidemic diet. Th e chemical analysis of the oyster mushroom indicates that the fruit bodies contain 54% carbohydrate, 16% protein, and 6% lipid along with lower concentrations of many other chemical substances. Th e physicochemical properties of the mushrooms and their extracts were extensively investigated. Th e molecular weight of the active fraction of the mushroom ethanolic extract was 304 kilodaltons. Th e NMR spectra indicated that the extract is glucan in nature. In order to investigate the hypocholesterolemic eff ect of the mushrooms, it was decided to evaluate the eff ect of this fungus on several biochemical criteria associated with atherosclerosis and coronary heart disease. Th e hamster model was chosen because its cholesterol metabolism has been found to be clearly similar to that of humans. Th e present work revealed that the addition of mushrooms to the diet did not aff ect the intake of other foods or the fi nal body weight of the hamsters. Results showed a signifi cant decrease in the tested serum and liver lipid parameters in hyperlipidemic hamsters given mushroom fruit bodies and their extract. Th e eff ect of mushroom ethanolic extract on acyl-CoA-cholesterol actyltransferase (ACAT) activity, apolipoprotein content, and phospholipid profi le-were studied. Results indicated that mushroom ethanolic extract reduced cholesterol absorption.
Our data confi rm the importance of ACAT for the absorption of dietary cholesterol in hamsters. Th e lethal dose value of ethanolic mushroom extract administered in hamsters was 660 mg/kg body weight. Estimation of enzymes representing liver function and glucose concentration was done in this study to illustrate if there were any side eff ects due to administration of mushroom extract to these hyperlipidemic hamsters. Th e hypocholesterolemic eff ect of mushroom ethanolic extract was less pronounced than the eff ect of a diet containing whole oyster mushroom. Similarly, the favorable redistribution of cholesterol in lipoproteins was less evident in the group given mushroom ethanolic extract compared to a diet containing whole mushroom.
